Dr. Christian Zahnd
Dr. Christian Zahnd is the Honorary Chairman of the Board of Directors of Molecular Partners. Dr. Zahnd co-founded the Company to expand his pioneering research on the therapeutic applications of DARPins. Dr. Zahnd was a member of the Company’s management team since its inception in 2004. He graduated with a Master of Science degree from the ETH Zurich and earned his PhD in Molecular Biology from the University of Zurich. His research focused on antibodies and antibody fragments, which he studied independently and through academic and industry collaborations.